Interventional radiology - Venous Physiology and Access

Venous Physiology and Disease Introduction The venous system is the body's crucial return pathway, carrying oxygen-poor blood from tissues back to the heart. Understanding how veins work normally is essential for recognizing what happens when things go wrong. This guide covers the basics of venous function, followed by two major clinical applications: creating access for dialysis in patients with kidney disease, and placing central lines for medication delivery. Basic Venous Blood Flow The venous system plays a fundamentally different role than arteries. While arteries distribute oxygen-rich blood at high pressure, veins collect oxygen-poor blood and return it to the heart—but at very low pressure. How pressure drives venous flow: Blood naturally flows from areas of high pressure to areas of low pressure. In the venous system, this pressure gradient is small. Blood leaves the heart through the aorta at high pressure (around 120/80 mmHg), gradually loses pressure as it travels through arteries and capillaries, and returns through veins at much lower pressure (typically 2-8 mmHg in peripheral veins). This low-pressure, low-resistance system allows veins to handle large volumes of blood without needing thick, muscular walls. Vein wall structure: Venous walls are thin and distensible (stretchy), which is fundamentally different from arterial walls. This means veins can accommodate large volumes of blood with only minimal increases in pressure. Think of veins as flexible storage vessels rather than high-pressure conduits. The role of venous valves: Because venous pressure is so low, blood could easily flow backward, especially in the legs where gravity works against upward flow. Venous valves prevent this retrograde (backward) flow. These are one-way gates made of valve flaps (cusps) that allow blood to move toward the heart but snap shut if blood tries to flow backward. The muscle pump: The body doesn't rely solely on heart contractions to push blood through veins. When you walk, run, or simply move your limbs, skeletal muscle contractions squeeze the veins around them. This acts like a pump, pushing blood upward against gravity. This is why prolonged immobility is dangerous—without the muscle pump working, blood can stagnate in leg veins. Major Venous Structures and Classification The vena cava is the body's largest vein, and it actually consists of two major segments: Superior vena cava (SVC): Drains blood from the head, neck, upper limbs, and thorax (everything above the diaphragm) into the right atrium. Inferior vena cava (IVC): Drains blood from the abdomen, pelvis, and lower limbs (everything below the diaphragm) into the right atrium. Veins throughout the body can be classified into two functional categories: Superficial veins: Located close to the skin and easily visible, these drain the soft tissues like skin and fat. Examples include the saphenous veins in the legs and cephalic vein in the arm. Deep veins: These accompany arteries and drain muscles and internal organs. Deep veins are not visible on the skin surface. This distinction matters clinically because superficial veins are easier to access surgically, while deep veins are more reliably patent (open) for medical purposes. Clinical Effects of Venous Stasis What is venous stasis? Venous stasis occurs when blood flow slows or stops in the venous system. This happens when the muscle pump fails—such as during prolonged bed rest, long flights, or immobilization after surgery. Why is stasis dangerous? When blood pools in veins instead of flowing, several problems develop: Edema (swelling): Fluid from stagnant blood leaks into surrounding tissues, causing swelling and discomfort. Pain: The pressure from pooled blood and swollen tissues causes pain, heaviness, and fatigue in affected limbs. Thrombosis: This is the most serious consequence. When blood sits still, it's more likely to clot. A blood clot in a vein (thrombosis) can completely block blood flow. If a clot breaks free and travels to the lungs, it becomes a pulmonary embolism—a life-threatening emergency. This is why patients are encouraged to move and exercise after surgery and why long-haul travelers are advised to get up and walk periodically. Dialysis Vascular Access Chronic Kidney Disease: The Clinical Context What is chronic kidney disease? Chronic kidney disease (CKD) is the progressive loss of kidney function over months or years. The kidneys gradually lose their ability to filter waste and excess water from the blood. Global impact: Approximately 14% of the world's population suffers from some degree of chronic kidney disease, making it a major public health issue. End-stage renal disease: The most severe stage is Stage 5 chronic kidney disease, also called end-stage renal disease (ESRD). At this point, the kidneys function at less than 15% of normal capacity. Patients cannot survive without renal replacement therapy—a mechanical process that replaces the kidney's filtering function. Hemodialysis is the most common form of renal replacement therapy. Why dialysis needs special access: During hemodialysis, blood is pumped out of the body, passed through a machine that filters waste and excess water, and then returned. This requires reliable, high-flow venous access that can withstand repeated needle sticks and high-volume blood flow (typically 300-500 mL/min). A regular peripheral IV vein cannot handle this demand. Types of Hemodialysis Vascular Access There are three main approaches to creating dialysis access, each with distinct advantages and limitations. Arteriovenous Fistula (AVF) An arteriovenous fistula is created by surgically connecting an artery directly to a vein, usually in the forearm. How it works: By connecting high-pressure arterial blood directly to a vein, the vein becomes "arterialized"—it experiences high-flow, high-pressure blood (instead of the normal low-pressure venous flow). Over weeks to months, the vein enlarges and its wall thickens, allowing it to handle the high-flow demands of dialysis. The enlarged vein creates a prominent bulge (called a "fistula thrill") that you can feel when you touch the arm. Why use it: Fistulas are the gold standard because they have the longest lifespan (many last 20+ years), lowest infection rates, and best outcomes overall. Drawbacks: They take weeks to mature before they can be used, so they cannot be created urgently. Also, not all patients have suitable anatomy for fistula creation. Arteriovenous Graft (AVG) An arteriovenous graft bridges an artery and a vein with a prosthetic tube, usually made of synthetic material like polytetrafluoroethylene (PTFE). How it works: The graft is surgically tunneled under the skin, connecting an artery (usually in the upper arm) to a vein. Blood flows from the artery through the graft to the vein, creating the necessary high-flow pathway. Advantages over AVF: Grafts can be used much sooner after placement (within 1-2 weeks instead of 4-6 weeks), making them useful when faster access is needed. Drawbacks: Grafts don't last as long as fistulas and have higher infection rates because the synthetic material can harbor bacteria. They typically last 3-5 years. Dialysis Catheters Dialysis catheters are placed in large central veins (usually the internal jugular vein or femoral vein) and provide direct central venous access. Temporary catheters: These non-tunneled catheters are placed at the bedside using ultrasound guidance. They're ideal for hospitalized patients with acute kidney injury who are critically ill or have high bleeding risk. Tunneled catheters: These have a subcutaneous tunnel (a path under the skin) running from the vein insertion site to an external exit site on the chest. The tunnel reduces infection risk because bacteria must travel through tissue to reach the bloodstream. Tunneled catheters can support long-term dialysis (months to years). Why catheters as last resort: While convenient, dialysis catheters have higher infection rates than fistulas or grafts and higher thrombosis rates. They're reserved for situations where an AVF or AVG is not yet available or not feasible. Complications of Arteriovenous Access Both AVF and AVG can develop serious problems that threaten dialysis function. Stenosis (Narrowing) What happens: Vascular stenosis is abnormal narrowing of the fistula or graft lumen. This develops due to neointimal hyperplasia—excessive growth of smooth muscle cells in the vessel wall, often triggered by the abnormal hemodynamics created by the high-flow access. Clinical consequence: As the lumen narrows, blood flow decreases. If flow drops below about 400 mL/min, the access may no longer deliver adequate dialysis. Patients may notice decreased thrill, swollen arm, or poor dialysis sessions. Thrombosis (Clotting) What happens: A blood clot forms within the fistula or graft, completely occluding the lumen. Causes: Thrombosis often develops as a consequence of stenosis. When flow becomes too slow, blood stagnates and clots. It can also occur from dehydration, hypotension, or repeated puncture trauma. Clinical consequence: Thrombosis causes sudden access failure—no blood can flow through the access, making dialysis impossible. This is a vascular emergency. Interventional Management of Dialysis Access When AVF or AVG complications develop, interventional radiologists and vascular surgeons can rescue the access using catheter-based techniques. Fistulography (Angiography) What it is: A fistulogram is an angiographic study (X-ray imaging with contrast dye) that visualizes the entire fistula or graft and surrounding vessels. Why it's needed: The fistulogram identifies stenosis, thrombosis, or other lesions responsible for access dysfunction. It also shows the anatomy, helping the physician plan intervention. Angioplasty What it is: Percutaneous transluminal angioplasty (PTA) uses a balloon catheter to dilate (widen) a stenosed segment. How it works: A catheter with a deflated balloon is advanced to the narrowed area. The balloon is inflated, forcefully expanding the vessel diameter and disrupting the narrowing. The balloon is then deflated and removed. Advantage: Angioplasty is minimally invasive—performed through a small catheter rather than open surgery. Limitation: Restenosis (re-narrowing) often occurs within weeks to months because the underlying smooth muscle hyperplasia is not treated, only the symptoms. Stent Placement What it is: A stent is a metal mesh scaffold that maintains vessel diameter after angioplasty. How it helps: When a stent is deployed at the angioplasty site, it physically holds the vessel open, reducing the rate of restenosis compared to angioplasty alone. Consideration: Stents may limit future surgical options if the access fails, so they're used selectively. Thrombectomy What it is: Mechanical removal of a blood clot from a thrombosed fistula or graft. Technique: A catheter is advanced to the clot, and the clot is mechanically removed (pulled out). Sometimes pharmacologic thrombolysis (dissolving the clot with medication) is used beforehand or in combination. Success: When successful, thrombectomy restores blood flow immediately. However, the underlying cause (usually stenosis) is also treated during the same procedure, or the access will re-thrombose. Endovascular Creation of Fistulas (Endo-AVF) What it is: A newer technique that creates an AVF using percutaneous (needle) techniques rather than open surgery. How it works: Catheters are used to create a channel between an artery and vein from inside the vessels. This avoids surgical incisions. Advantage: Minimally invasive, potential for shorter maturation time. Status: Still evolving as a technique; not yet a standard of care everywhere. Access Site Selection for Dialysis Catheters When a temporary or tunneled dialysis catheter is needed, the insertion site matters significantly. Preferred Site: Right Internal Jugular Vein The right internal jugular vein is the gold standard for dialysis catheter placement. Why preferred: The right IJV has a relatively straight, direct path to the superior vena cava and right atrium. This makes catheter placement easier, reduces the risk of catheter malposition, and minimizes angulation that could impede flow or cause complications. Alternative Sites Left internal jugular vein: Can be used when the right side is unavailable (previous catheter, thrombosis, infection, or anatomic abnormality). The left IJV has a longer, more angulated path to the right atrium, increasing the risk of complications, but it's still acceptable. Femoral vein: Can be used when both internal jugular sites are unavailable. The femoral vein is lower on the body, making it less ideal because the catheter tip is farther from the heart. However, it's still a functional option for dialysis. Central Venous Access for Medications Indications for Central Venous Catheters Central venous catheters (CVCs) have important uses beyond dialysis, particularly for medication delivery. High-Potency Medications Some medications are extremely irritating or sclerosing to peripheral veins. Examples include: Chemotherapy: Anticancer drugs are caustic and can cause severe tissue damage if they leak into the surrounding tissue. Central venous access ensures the medication reaches the heart's circulation immediately, diluted in fast-flowing blood. Vasopressors: Medications that raise blood pressure are too potent for peripheral veins. Hypertonic solutions: Concentrated salt or sugar solutions irritate peripheral veins. Long-Term Antibiotic Therapy Some infections (like osteomyelitis or endocarditis) require weeks or months of intravenous antibiotics. Rather than subjecting the patient to repeated peripheral IV placements (which are uncomfortable and can cause thrombophlebitis), a central line allows long-term access through a single device. Types of Central Venous Catheters Hickman Catheters What it is: A Hickman catheter is a tunneled central venous catheter with a Dacron cuff. Design: The catheter is tunneled under the skin from the vein insertion site to an exit site on the chest. The Dacron cuff is a collar of material that sits in the subcutaneous tunnel—it acts as a barrier to infection by causing tissue ingrowth that seals the tract. Advantages: The tunnel and cuff substantially reduce infection risk. Long-term durability makes Hickman catheters ideal for extended therapy. Use: Hickman catheters are commonly used for long-term chemotherapy or prolonged antibiotic courses. Peripherally Inserted Central Catheters (PICCs) What it is: A PICC line is inserted through a peripheral vein in the arm and advanced into a central vein. Technique: The catheter is typically placed through an antecubital vein (in the elbow crease) and threaded into the superior vena cava using imaging guidance. Advantages: Can be placed at the bedside without surgery; uses peripheral rather than central access, reducing risk of complications like pneumothorax or arterial puncture. Limitation: PICCs are generally not suitable for high-flow dialysis but work well for medications. Mediports (Implantable Ports) What it is: A mediport (or portacath) is an implantable port-catheter system consisting of a reservoir (port) with a septum and an attached catheter. How it works: The entire device is implanted under the skin. The port has a self-sealing rubber septum that allows repeated needle punctures without leaking. The attached catheter is placed in a central vein. Advantages: Completely implanted, so there's no external device to keep clean; low infection risk; can be accessed repeatedly; excellent for intermittent therapies (like chemotherapy given monthly). Access method: When therapy is needed, a special needle (Huber needle) is inserted through the skin into the port's septum. Insertion Sites and Positioning Common Insertion Sites Central venous catheters are placed in three main locations: Internal jugular vein: Most commonly used; direct route to the superior vena cava with minimal angulation. Subclavian vein: Offers a relatively straight path but carries a higher risk of complications like pneumothorax (lung collapse due to needle puncture). Femoral vein: Used when upper body access is unavailable; longer path to the heart means the catheter tip is farther from ideal position. Optimal Tip Position The catheter tip should be positioned in the superior vena cava near the right atrium. Why this matters: This position ensures optimal hemodynamics for drug delivery. The tip bathes in fast-flowing blood, immediately diluting medications. A malpositioned tip (in the right atrium itself, in a smaller vein, or in an unusual location) can cause complications like arrhythmias, thrombus formation, or inadequate infusion rates. Verification: Chest X-ray after placement confirms the tip is in the correct location. Imaging Guidance and Placement Technique Universal Use of Imaging Guidance A critical principle: All central venous catheter placements must be performed under imaging guidance. No exceptions. Available modalities: Ultrasound: Real-time imaging showing the vein's location, size, patency, and the needle approaching the vessel. Most commonly used for internal jugular and subclavian placements. Fluoroscopy: X-ray imaging, particularly useful for confirming final catheter position and checking for complications. CT guidance: Used in complex cases or when other modalities fail. Why Imaging is Essential Vessel puncture: Imaging ensures the needle actually enters the intended vein. Blind landmark-based placement (using anatomic landmarks alone) has unacceptably high failure rates. Avoiding arterial injury: The internal jugular and subclavian regions contain important arteries (carotid and subclavian arteries respectively). Real-time ultrasound shows whether you've accidentally punctured an artery, allowing immediate correction before serious bleeding occurs. Confirming tip location: Post-placement imaging confirms the catheter tip is in the superior vena cava, not in the right atrium, a tributary vein, or inadvertently in the arterial system.